Determination of cerebrospinal fluid adenosine deaminase activity cut-off for the diagnosis of tuberculous meningitis in Hong Kong.

Toby Chun Hei Chan Sammy Pak Lam ChenChloe Miu MakChor Kwan ChingKristine Shik LukYat Ming TsangDaniel Cheuk Wa Leung

Published in: Journal of clinical pathology (2020)

We recommend the use of CSF-ADA activity, which is a simple, fast and robust test for early differentiation of TBM from other causes, to facilitate timely initiation of antituberculous treatment and potentially improve patients' outcome.

Keyphrases

cerebrospinal fluid
end stage renal disease
newly diagnosed
ejection fraction
prognostic factors
peritoneal dialysis
mass spectrometry
patient reported outcomes